Tuberculosis and COVID-19 co-infection: description of the global cohort:

The TB/COVID-19 Global Study Group. Corresponding author: Giovanni Battista Migliori

24 March, 2022

NZ Respiratory Research Review Issue 199

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial:

Veronique De Jager, Nikhil Gupte, Silvia Nunes, Grace L. Barnes, Rob Christiaan van Wijk, Joni Mostert, Susan E. Dorman, Ahmed A. Abulfathi, Caryn M. Upton, Alan Faraj, Eric L. Nuermberger, Gyanu Lamichhane, Elin M. Svensson, Ulrika S. H. Simonsson, Andreas H. Diacon, Kelly E. Dooley, and the COMRADE Study Team

8 March, 2022

NZ Respiratory Research Review Issue 199

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study):

Aliasgar Esmail, Suzette Oelofse, Carl Lombard, Rubeshan Perumal, Linda Mbuthini, Akhter Goolam Mahomed, Ebrahim Variava, John Black, Patrick Oluboyo, Nelile Gwentshu, Eric Ngam, Tertius Ackerman, Linde Marais, Lynelle Mottay, Stuart Meier, Anil Pooran, Michele Tomasicchio, Julian Te Riele, Brigitta Derendinger, Norbert Ndjeka, Gary Maartens, Robin Warren, Neil Martinson, and Keertan Dheda

17 February, 2022

NZ Respiratory Research Review Issue 199

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism The Kids-DOTT Randomized Clinical Trial:

Neil A. Goldenberg, MD, PhD; John M. Kittelson, PhD; Thomas C. Abshire, MD; et al

11 January, 2022

NZ Respiratory Research Review Issue 195

Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease:

Naoki Takasaka Yusuke Hosaka Taiki Fukuda Kyota Shinfuku Kentaro Chida Shun Shibata Ayako Kojima Tsukasa Hasegawa Masami Yamada Yumie Yamanaka Aya Seki Yoshitaka Seki Takeo Ishikawa Kazuyoshi Kuwano

10 January, 2022

NZ Respiratory Research Review Issue 199

Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension:

Natalia J. Braams, Gudula J.A.M. Boon, Frances S. de Man, Josien van Es, Paul L. den Exter, Lucia J.M. Kroft, Ludo F.M. Beenen, Menno V. Huisman, Esther J. Nossent, Anco Boonstra, Anton Vonk Noordegraaf, Dieuwertje Ruigrok, Frederikus A. Klok, Harm Jan Bogaard, Lilian J. Meijboom

23 December, 2021

NZ Respiratory Research Review Issue 195

Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism A Randomized Clinical Trial:

Yonathan Freund, MD, PhD; Anthony Chauvin, MD, PhD; Sonia Jimenez, MD; et al

7 December, 2021

NZ Respiratory Research Review Issue 195

Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality:

Yunjoo Im, MD, PhD Na Young Hwang, PhD Kyunga Kim, PhD Hojoong Kim, MD, PhD O. Jung Kwon, MD, PhD Byung Woo Jhun, MD, PhD

15 November, 2021

NZ Respiratory Research Review Issue 199

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study:

Prof Nazir Ahmed Ismail, FCPath, Shaheed Vally Omar, PhD, Harry Moultrie, MBChB, Zaheda Bhyat, BTech, Francesca Conradie, MBChB, M Enwerem, MBBS et al.

12 November, 2021

NZ Respiratory Research Review Issue 199

Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools:

Erick W. Bunyasi, Keren Middelkoop, Anastasia Koch, Zeenat Hoosen, Humphrey Mulenga, Angelique K. K. Luabeya, Justin Shenje, Simon C. Mendelsohn, Michele Tameris, Thomas J. Scriba, Digby F. Warner, Robin Wood, Jason R. Andrews, and Mark Hatherill

9 November, 2021

NZ Respiratory Research Review Issue 199